The COVID-19 vaccine produced by China’s Sinovac Biotech has entered phase 3 trial globally. Helen Yang from the company says the clinical trial will be completed by the end of the year and the vaccine will be available soon in the market at an affordable price after approval.
Watch CGTN LIVE on your computer, tablet or mobile
Subscribe to CGTN America on YouTube
Follow CGTN America: